BUFFERED FORMULATIONS OF BEVACIZUMAB FOR USE OF TREATING DISEASES

The invention provides buffered aqueous formulations of bevacizumab. The invention further provides methods of making buffered formulations of bevacizumab. The invention provides methods of treating eye disorders, particularly wet age-related macular degeneration and macular edema by administering the buffered antibody compositions of the disclosure. 本发明提供了贝伐珠单抗的缓冲水性制剂。本发明进一步提供了制备贝伐珠单抗的缓冲制剂的方法。本发明提供了通过施用本公开内容的缓冲抗体组合物来治疗眼病、特别是湿性年龄相关性黄斑变性和黄斑水肿的方法。